StockData
Apyx Medical Corp logo

Apyx Medical Corp (APYX) stock

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$3.00+0.07 (+2.39%)

Close on Nov 11, 2026Market cap $126.37MP/E –Yield –

Apyx Medical statistics

88 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 9, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$126.37M
$522.32M
Enterprise Value
$136.57M
$447.89M
PS Ratio
2.12
3.10
PB Ratio
13.12
3.20
P/TBV Ratio
13.12
5.16

Enterprise valuationIndustry

EV / Sales
2.29
2.87

Share statisticsIndustry

Shares Change (YoY)
8.33%
3.22%
Shares Change (QoQ)
0.02%
0.18%
Float
39M
38M
Shares Held by Insiders
6.77%
10.5%
Shares Held by Institutions
58.5%
60.2%

Short sellingIndustry

Short Interest
245,424
–
Short Interest Change
14.8%
-2.57%
Short % of Float
0.62%
5.09%
Short % of Shares Outstanding
0.58%
3.88%
Days to Cover
2.08
3.94

Stock price statisticsIndustry

52-Week High
$5.08
–
52-Week Low
$2.25
–
20-Day Moving Average
$2.64
–
50-Day Moving Average
$2.73
–
200-Day Moving Average
$3.56
–
Average True Range (14)
$0.20
–
Price Change (1 Week)
15.8%
-0.73%
Price Change (1 Month)
15.4%
-0.65%
Price Change (3 Months)
-1.32%
-6.51%
Price Change (6 Months)
-21.9%
0.80%
Price Change (YTD)
-14.3%
1.08%
Price Change (1 Year)
-26.8%
-2.00%
Price Change (3 Years)
70.9%
11.1%
Price Change (5 Years)
-81.9%
-45.3%
Price Change (10 Years)
-24.4%
59.1%
Average Volume (10 Days)
179,808
–
Average Volume (20 Days)
160,395
–
Average Volume (90 Days)
131,541
–
Relative Volume
0.26
0.81
Relative Strength Index (14)
62.9
50.1
Volatility (1 Year)
73.8%
64.2%
Beta (5 Years)
1.49
1.05

MarginsIndustry

Gross Margin
63.4%
55.9%
Operating Margin
-5.50%
-5.12%
Pretax Margin
-13.1%
-2.65%
Profit Margin
-14.2%
-9.65%
EBITDA Margin
-4.15%
-2.82%
FCF Margin
-14.9%
0.40%

Returns on capitalIndustry

Return on Equity (ROE)
-109.0%
-16.6%
Return on Assets (ROA)
-14.2%
-12.4%
Return on Invested Capital (ROIC)
-14.9%
-2.94%
Return on Capital Employed (ROCE)
-6.45%
-7.90%

Financial positionIndustry

Current Ratio
4.95
2.48
Quick Ratio
3.74
1.52
Debt / Equity
3.69
0.42
Interest Coverage
-0.59
-1.68

GrowthIndustry

Revenue Growth (YoY)
24.4%
9.42%
Revenue Growth (3Y CAGR)
5.89%
7.08%
Revenue Growth (5Y CAGR)
13.8%
11.8%

EfficiencyIndustry

Asset Turnover
1.00
0.59
Inventory Turnover
2.06
2.20
Revenue Per Employee
$290.58K
$330.60K
Profits Per Employee
-$41.15K
-$41.63K
Employee Count
205
186
WACC
12.2%
9.78%

Income statement (TTM)Industry

Revenue
$59.57M
$106.73M
Gross Profit
$37.80M
$62.29M
Operating Income
-$3.28M
-$3.39M
Pretax Income
-$7.78M
-$1.98M
Net Income
-$8.44M
-$6.40M
EBITDA
-$2.47M
-$1.98M
EPS (Diluted)
-$0.19
-$0.07

Balance sheetIndustry

Total Debt
$35.57M
$96.00M
Net Cash (Debt)
-$9.80M
$3.85M
Net Cash Per Share
-$0.23
$0.23
Equity (Book Value)
$9.63M
$63.44M
Book Value Per Share
$0.23
$3.11
Tangible Book Value
$9.63M
$11.04M
Working Capital
$42.97M
$56.85M

Cash flow (TTM)Industry

Operating Cash Flow
-$8.23M
-$483.87K
Capital Expenditures
-$666.00K
-$3.69M
Free Cash Flow
-$8.89M
-$387.37K
FCF Per Share
-$0.21
-$0.01

Dividends and yieldsIndustry

Earnings Yield
-6.67%
-4.70%
FCF Yield
-7.04%
0.25%

Taxes and interestIndustry

Interest Expense
$5.58M
$5.33M
Income Tax
$477.00K
$1.63M

Scores and fair valueIndustry

Altman Z-Score
0.91
2.54
Piotroski F-Score
5
5
Beneish M-Score
-2.63
-2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodAPYXS&P 500DifferenceAPYX per yearS&P 500 per year
1 month+15.8%-2.4%+18.2 pts
3 months-0.7%-1.2%+0.5 pts
Year to date-14.3%+12.3%−26.6 pts
1 year-25.0%+12.4%−37.4 pts
3 years+70.9%+78.8%−7.9 pts+19.6%+21.4%
5 years-79.5%+75.2%−154.6 pts-27.1%+11.9%
10 years-24.4%+311.1%−335.5 pts-2.8%+15.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M APYX shares were sold short on Oct 30, 2026, up 14.8% from the previous report, or 0.62% of the shares available to trade. At recent volumes it would take 2.1 days to buy them back. Over the last 20 sessions, 29.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026245,424+14.8%118,1062.1
Oct 15, 2026213,730+3.3%118,9151.8
Sep 30, 2026206,825-5.1%176,5601.2
Sep 15, 2026218,049+6.3%88,4932.5
Aug 31, 2026205,197-10.9%160,8141.3
Aug 14, 2026230,354-13.8%154,2431.5
Jul 31, 2026267,145+6.1%56,9504.7
Jul 15, 2026251,668+42.0%64,8143.9
Jun 30, 2026177,278+26.9%147,4731.2
Jun 15, 2026139,664-34.1%200,0161.0
May 29, 2026211,948+26.6%115,6231.8
May 15, 2026167,446-24.3%351,0361.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?